Regeneron Pharmaceuticals Stock: Analyst Estimates & Ratings
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Despite Regeneron Pharmaceuticals’ underperformance relative to the broader market over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1036554940-c4c846ff8f1b49ef95b59e908088153b.jpg "Here’s How Much the Average Retired Person Spends Per Month. Will You Have Enough?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1137356798-07a2e94fdba4405e80e24e125ae9fb74.jpg "<div>The Economics of Mexico's Middle Class</div>")